A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study

Am J Hematol. 2024 Mar 14. doi: 10.1002/ajh.27289. Online ahead of print.

Authors

Affiliations

¹ Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
² Department of Hematology, Weinan Central Hospital, Weinan, China.

PMID: 38482543
DOI: 10.1002/ajh.27289

No abstract available

Publication types

Letter

Grants and funding